Regenxbio (RGNX) Return on Equity [ROE] (2015 - 2026)
Regenxbio (RGNX) posted Return on Equity [ROE] of -423.28% for Q2 2026, down 351.24 percentage points from -72.04% a year earlier but up 45.30 percentage points from the prior quarter.
Regenxbio (RGNX) Return on Equity [ROE] (2015 - 2026) Analysis & Trends
For FY2025, Regenxbio's Return on Equity [ROE] came in at -107.05%, down 27.56 percentage points from FY2024.
- Annual Return on Equity [ROE] has declined for four consecutive years, with a five-year change of -80.17 percentage points (FY2020 to FY2025).
- In prior years, Regenxbio's Return on Equity [ROE] was -79.49% in FY2024 (-15.84 pp), -63.65% in FY2023 (-19.87 pp), -43.78% in FY2022 (-66.17 pp) and 22.39% in FY2021 (+49.26 pp).
- Quarterly Return on Equity [ROE] has run from a low of -468.58% in Q1 2026 to a high of 20.86% in Q4 2021 over five years.
- On a year-over-year basis, Return on Equity [ROE] has declined in each of the last five quarters, with an average year-over-year change of -106.04 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2022, with a gain of 56.19 percentage points; the weakest was Q1 2026, with a drop of 409.44 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -468.58% (Q1 2026), -146.84% (Q4 2025) and -94.93% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Regenxbio | 508.48 Mn | -228.57 Mn | - | -159.66% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -159.66% |
| Jun 30, 2026 | -423.07% |
| Mar 31, 2026 | -468.36% |
| Dec 31, 2025 | -146.74% |
| Sep 30, 2025 | -94.89% |
| Jun 30, 2025 | -71.35% |
| Mar 31, 2025 | -58.15% |
| Dec 31, 2024 | -79.64% |
| Sep 30, 2024 | -71.41% |
| Jun 30, 2024 | -63.13% |
| Mar 31, 2024 | -71.68% |
| Dec 31, 2023 | -74.84% |
| Sep 30, 2023 | -64.94% |
| Jun 30, 2023 | -61.88% |
| Mar 31, 2023 | -55.02% |
| Dec 31, 2022 | -54.29% |
| Sep 30, 2022 | 9.70% |
| Jun 30, 2022 | 11.89% |
| Mar 31, 2022 | 12.65% |
| Dec 31, 2021 | 20.71% |
Regenxbio Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RGNX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();